Table 3.
Trends in age-standardized incidence rates for selected cancers by sex in China, 2000 to 2018.
| Sex | Site | Trend 1 |
Trend 2 |
Trend 3 |
AAPC, % (95% CI) |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| Years | APC, % (95% CI) | Years | APC, % (95% CI) | Years | APC, % (95% CI) | 2000–2018 | 2009–2018 | 2014–2018 | ||
| Both | All sites | 2000–2014 | 1.1⁎ (0.8–1.3) | 2014–2018 | 2.5⁎ (0.8–4.1) | – | – | 1.4⁎ (1.0–1.8) | 1.7⁎ (1.0–2.4) | 2.5⁎ (0.8–4.1) |
| Males | All sites | 2000–2018 | 0.3⁎ (0.1–0.4) | – | – | – | – | 0.3⁎ (0.1–0.4) | 0.3⁎ (0.1–0.4) | 0.3⁎ (0.1–0.4) |
| Esophagus | 2000–2018 | −3.5⁎ (−3.8 to −3.3) | – | – | – | – | −3.5⁎ (−3.8 to −3.3) | −3.5⁎ (−3.8 to −3.3) | −3.5⁎ (−3.8 to −3.3) | |
| Stomach | 2000–2004 | −4.6⁎ (−6.0 to −3.1) | 2004–2009 | −1.3 (−2.8–0.3) | 2009–2018 | −3.1⁎ (−3.6 to −2.7) | −2.9⁎ (−3.5 to −2.4) | −3.1⁎ (−3.6 to −2.7) | −3.1⁎ (−3.6 to −2.7) | |
| Colon-rectum | 2000–2006 | 4.3⁎ (3.5–5.1) | 2006–2014 | 1.1⁎ (0.5–1.7) | 2014–2018 | 3.5⁎ (2.0–5.0) | 2.7⁎ (2.2–3.1) | 2.2⁎ (1.5–2.8) | 3.5⁎ (2.0–5.0) | |
| Liver | 2000–2006 | −0.9 (−2.0–0.2) | 2006–2018 | −2.9⁎ (−3.3 to −2.6) | – | – | −2.3⁎ (−2.7 to −1.9) | −2.9⁎ (−3.3 to −2.6) | −2.9⁎ (−3.3 to −2.6) | |
| Pancreas | 2000–2018 | 1.0⁎ (0.8–1.2) | – | – | – | – | 1.0⁎ (0.8–1.2) | 1.0⁎ (0.8–1.2) | 1.0⁎ (0.8–1.2) | |
| Lung | 2000–2014 | −0.2 (−0.4–0.1) | 2014–2018 | 2.7⁎ (0.9–4.6) | – | – | 0.5⁎ (0.1–0.9) | 1.1⁎ (0.4–1.8) | 2.7⁎ (0.9–4.6) | |
| Prostate | 2000–2005 | 12.2⁎ (10.3–14.2) | 2005–2018 | 5.1⁎ (4.6–5.5) | – | – | 7.0⁎ (6.5–7.6) | 5.1⁎ (4.6–5.5) | 5.1⁎ (4.6–5.5) | |
| Bladder | 2000–2005 | 4.3⁎ (2.4–6.3) | 2005–2018 | −0.5⁎ (−1.0 to −0.1) | – | – | 0.8⁎ (0.3–1.4) | −0.5⁎ (−1.0 to −0.1) | −0.5⁎ (−1.0 to −0.1) | |
| Thyroid | 2000–2007 | 11.8⁎ (9.0–14.7) | 2007–2014 | 27.0⁎ (23.0–31.2) | 2014–2018 | 9.2⁎ (2.8–16.1) | 16.9⁎ (14.7–19.1) | 18.8⁎ (15.4–22.3) | 9.2⁎ (2.8–16.1) | |
| Lymphoma | 2000–2004 | 6.8⁎ (2.9–10.8) | 2004–2012 | −0.3 (−1.9–1.2) | 2012–2018 | 2.5⁎ (0.5–4.6) | 2.2⁎ (1.0–3.3) | 1.6⁎ (0.3–2.9) | 2.5⁎ (0.5–4.6) | |
| Females | All sites | 2000–2006 | 2.8⁎ (1.8–3.8) | 2006–2011 | 1.4 (−0.4–3.2) | 2011–2018 | 3.2⁎ (2.4–4.0) | 2.6⁎ (1.9–3.2) | 2.8⁎ (2.1–3.4) | 3.2⁎ (2.4–4.0) |
| Esophagus | 2000–2004 | −8.0⁎ (−11.3 to −4.6) | 2004–2009 | −3.9⁎ (−7.4 to −0.3) | 2009–2018 | −7.0⁎ (−7.9 to −6.0) | −6.4⁎ (−7.5 to −5.2) | −7.0⁎ (−7.9 to −6.0) | −7.0⁎ (−7.9 to −6.0) | |
| Stomach | 2000–2018 | −2.8⁎ (−3.0 to −2.6) | – | – | – | – | −2.8⁎ (−3.0 to −2.6) | −2.8⁎ (−3.0 to −2.6) | −2.8⁎ (−3.0 to −2.6) | |
| Colon-rectum | 2000–2006 | 3.1⁎ (2.1–4.1) | 2006–2018 | 0.2 (−0.1–0.5) | – | – | 1.1⁎ (0.8–1.5) | 0.2 (−0.1–0.5) | 0.2 (−0.1–0.5) | |
| Liver | 2000–2009 | −1.7⁎ (−2.5 to −1.0) | 2009–2014 | −4.3⁎ (−6.8 to −1.6) | 2014–2018 | −1.5 (−4.1–1.2) | −2.4⁎ (−3.3 to −1.5) | −3.0⁎ (−4.7 to −1.4) | −1.5 (−4.1–1.2) | |
| Lung | 2000–2013 | 1.1⁎ (0.6–1.7) | 2013–2018 | 8.3⁎ (6.0–10.7) | – | – | 3.1⁎ (2.4–3.8) | 5.1⁎ (3.9–6.2) | 8.3⁎ (6.0–10.7) | |
| Breast | 2000–2006 | 5.2⁎ (3.6–6.8) | 2006–2018 | 2.1⁎ (1.6–2.7) | – | – | 3.1⁎ (2.6–3.7) | 2.1⁎ (1.6–2.7) | 2.1⁎ (1.6–2.7) | |
| Cervix | 2000–2008 | 14.8⁎ (12.5–17.0) | 2008–2018 | 1.7⁎ (0.3–3.1) | – | – | 7.3⁎ (6.2–8.4) | 1.7⁎ (0.3–3.1) | 1.7⁎ (0.3–3.1) | |
| Uterus | 2000–2005 | 5.5⁎ (3.2–7.9) | 2005–2018 | 2.6⁎ (2.0–3.1) | – | – | 3.4⁎ (2.7–4.1) | 2.6⁎ (2.0–3.1) | 2.6⁎ (2.0–3.1) | |
| Ovary | 2000–2006 | 6.3⁎ (4.8–7.9) | 2006–2011 | −2.8⁎ (−5.4 to −0.2) | 2011–2018 | 0.7 (−0.4–1.9) | 1.5⁎ (0.6–2.4) | −0.1 (−1.0–0.9) | 0.7 (−0.4–1.9) | |
| Thyroid | 2000–2004 | 8.3⁎ (1.9–15.2) | 2004–2014 | 21.8⁎ (19.7–24.0) | 2014–2018 | 8.5⁎ (2.1–15.3) | 15.7⁎ (13.5–17.9) | 15.7⁎ (12.8–18.7) | 8.5⁎ (2.1–15.3) | |
⁎
The APC or AAPC is significantly different from zero (P < 0.05).
Abbreviations: AAPC, average annual percentage change; APC, annual percentage change; CI, confidence interval.